Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Bailey

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Australian Journal of General Practice|June 18, 2019
Differentiating between benign and malignant thyroid nodules: An evidence-based approach in general practiceStuart Bailey, Benjamin Wallwork
Journal of Biopharmaceutical Statistics|April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariatesStuart Bailey, Beat Neuenschwander, Glen Laird, et al.
Pharmaceutical Statistics|December 20, 2015
Robust exchangeability designs for early phase clinical trials with multiple strataBeat Neuenschwander, Simon Wandel, Satrajit Roychoudhury, et al.
Science & Justice : Journal of the Forensic Science Society|February 6, 2013
Recovery of human DNA profiles from poached deer remains part 2: improved recovery protocol without the need for LCN analysisShanan S Tobe, Stuart Bailey, James Govan, et al.
Pharmaceutical Statistics|April 1, 2021
Incorporating historical information to improve phase I clinical trialsYanhong Zhou, J Jack Lee, Shunguang Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Advancing Clinical Trials to Streamline Drug DevelopmentSusan E Bates, Donald A Berry, Sanjeeve Balasubramaniam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted TherapyLei Nie, Eric H Rubin, Nitin Mehrotra, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Machine learning for clinical trials in the era of COVID-19William R Zame, Ioana Bica, Cong Shen, et al.
Sports Medicine (Auckland, N.Z.)|May 16, 2023
Injury Rates, Mechanisms, Risk Factors and Prevention Strategies in Youth Rugby Union: What's All the Ruck-Us About? A Systematic Review and Meta-analysisStephen W West, Isla J Shill, Stuart Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumorsCristiana Sessa, Geoffrey I Shapiro, Kapil N Bhalla, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Australian Journal of General Practice|June 18, 2019
Differentiating between benign and malignant thyroid nodules: An evidence-based approach in general practiceStuart Bailey, Benjamin Wallwork
Journal of Biopharmaceutical Statistics|April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariatesStuart Bailey, Beat Neuenschwander, Glen Laird, et al.
Pharmaceutical Statistics|December 20, 2015
Robust exchangeability designs for early phase clinical trials with multiple strataBeat Neuenschwander, Simon Wandel, Satrajit Roychoudhury, et al.
Science & Justice : Journal of the Forensic Science Society|February 6, 2013
Recovery of human DNA profiles from poached deer remains part 2: improved recovery protocol without the need for LCN analysisShanan S Tobe, Stuart Bailey, James Govan, et al.
Pharmaceutical Statistics|April 1, 2021
Incorporating historical information to improve phase I clinical trialsYanhong Zhou, J Jack Lee, Shunguang Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Advancing Clinical Trials to Streamline Drug DevelopmentSusan E Bates, Donald A Berry, Sanjeeve Balasubramaniam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted TherapyLei Nie, Eric H Rubin, Nitin Mehrotra, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Machine learning for clinical trials in the era of COVID-19William R Zame, Ioana Bica, Cong Shen, et al.
Sports Medicine (Auckland, N.Z.)|May 16, 2023
Injury Rates, Mechanisms, Risk Factors and Prevention Strategies in Youth Rugby Union: What's All the Ruck-Us About? A Systematic Review and Meta-analysisStephen W West, Isla J Shill, Stuart Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2013
First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumorsCristiana Sessa, Geoffrey I Shapiro, Kapil N Bhalla, et al.
Pageof 2